168 related articles for article (PubMed ID: 29946776)
1. The Intricate Metabolism of Pancreatic Cancers.
Camelo F; Le A
Adv Exp Med Biol; 2018; 1063():73-81. PubMed ID: 29946776
[TBL] [Abstract][Full Text] [Related]
2. The Intricate Metabolism of Pancreatic Cancers.
Camelo F; Le A
Adv Exp Med Biol; 2021; 1311():77-88. PubMed ID: 34014535
[TBL] [Abstract][Full Text] [Related]
3. Unique metabolic features of pancreatic cancer stroma: relevance to the tumor compartment, prognosis, and invasive potential.
Knudsen ES; Balaji U; Freinkman E; McCue P; Witkiewicz AK
Oncotarget; 2016 Nov; 7(48):78396-78411. PubMed ID: 27623078
[TBL] [Abstract][Full Text] [Related]
4. Employing Metabolism to Improve the Diagnosis and Treatment of Pancreatic Cancer.
Halbrook CJ; Lyssiotis CA
Cancer Cell; 2017 Jan; 31(1):5-19. PubMed ID: 28073003
[TBL] [Abstract][Full Text] [Related]
5. Pancreatic tumor cell metabolism: focus on glycolysis and its connected metabolic pathways.
Guillaumond F; Iovanna JL; Vasseur S
Arch Biochem Biophys; 2014 Mar; 545():69-73. PubMed ID: 24393743
[TBL] [Abstract][Full Text] [Related]
6. HIF-2α regulates non-canonical glutamine metabolism via activation of PI3K/mTORC2 pathway in human pancreatic ductal adenocarcinoma.
Li W; Chen C; Zhao X; Ye H; Zhao Y; Fu Z; Pan W; Zheng S; Wei L; Nong T; Li Z; Chen R
J Cell Mol Med; 2017 Nov; 21(11):2896-2908. PubMed ID: 28544376
[TBL] [Abstract][Full Text] [Related]
7. JTC801 Induces pH-dependent Death Specifically in Cancer Cells and Slows Growth of Tumors in Mice.
Song X; Zhu S; Xie Y; Liu J; Sun L; Zeng D; Wang P; Ma X; Kroemer G; Bartlett DL; Billiar TR; Lotze MT; Zeh HJ; Kang R; Tang D
Gastroenterology; 2018 Apr; 154(5):1480-1493. PubMed ID: 29248440
[TBL] [Abstract][Full Text] [Related]
8. Phellodendrine chloride suppresses proliferation of KRAS mutated pancreatic cancer cells through inhibition of nutrients uptake via macropinocytosis.
Thu PM; Zheng ZG; Zhou YP; Wang YY; Zhang X; Jing D; Cheng HM; Li J; Li P; Xu X
Eur J Pharmacol; 2019 May; 850():23-34. PubMed ID: 30716311
[TBL] [Abstract][Full Text] [Related]
9. Mutant
Perets R; Greenberg O; Shentzer T; Semenisty V; Epelbaum R; Bick T; Sarji S; Ben-Izhak O; Sabo E; Hershkovitz D
Oncologist; 2018 May; 23(5):566-572. PubMed ID: 29371474
[TBL] [Abstract][Full Text] [Related]
10. Metabolic plasticity in heterogeneous pancreatic ductal adenocarcinoma.
Liang C; Qin Y; Zhang B; Ji S; Shi S; Xu W; Liu J; Xiang J; Liang D; Hu Q; Ni Q; Xu J; Yu X
Biochim Biophys Acta; 2016 Dec; 1866(2):177-188. PubMed ID: 27600832
[TBL] [Abstract][Full Text] [Related]
11. Mitochondrial glutamine metabolism via GOT2 supports pancreatic cancer growth through senescence inhibition.
Yang S; Hwang S; Kim M; Seo SB; Lee JH; Jeong SM
Cell Death Dis; 2018 Jan; 9(2):55. PubMed ID: 29352139
[TBL] [Abstract][Full Text] [Related]
12. Complex HuR function in pancreatic cancer cells.
Brody JR; Dixon DA
Wiley Interdiscip Rev RNA; 2018 May; 9(3):e1469. PubMed ID: 29452455
[TBL] [Abstract][Full Text] [Related]
13. Metabolic rewiring of pancreatic ductal adenocarcinoma: New routes to follow within the maze.
Olivares O; Vasseur S
Int J Cancer; 2016 Feb; 138(4):787-96. PubMed ID: 25732227
[TBL] [Abstract][Full Text] [Related]
14. Arginine Methylation of MDH1 by CARM1 Inhibits Glutamine Metabolism and Suppresses Pancreatic Cancer.
Wang YP; Zhou W; Wang J; Huang X; Zuo Y; Wang TS; Gao X; Xu YY; Zou SW; Liu YB; Cheng JK; Lei QY
Mol Cell; 2016 Nov; 64(4):673-687. PubMed ID: 27840030
[TBL] [Abstract][Full Text] [Related]
15. Paraoxonase 2 Facilitates Pancreatic Cancer Growth and Metastasis by Stimulating GLUT1-Mediated Glucose Transport.
Nagarajan A; Dogra SK; Sun L; Gandotra N; Ho T; Cai G; Cline G; Kumar P; Cowles RA; Wajapeyee N
Mol Cell; 2017 Aug; 67(4):685-701.e6. PubMed ID: 28803777
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of glutamine metabolism counteracts pancreatic cancer stem cell features and sensitizes cells to radiotherapy.
Li D; Fu Z; Chen R; Zhao X; Zhou Y; Zeng B; Yu M; Zhou Q; Lin Q; Gao W; Ye H; Zhou J; Li Z; Liu Y; Chen R
Oncotarget; 2015 Oct; 6(31):31151-63. PubMed ID: 26439804
[TBL] [Abstract][Full Text] [Related]
17. The critical roles of activated stellate cells-mediated paracrine signaling, metabolism and onco-immunology in pancreatic ductal adenocarcinoma.
Fu Y; Liu S; Zeng S; Shen H
Mol Cancer; 2018 Feb; 17(1):62. PubMed ID: 29458370
[TBL] [Abstract][Full Text] [Related]
18. Pancreatic cancer stem cells: A state or an entity?
Hermann PC; Sainz B
Semin Cancer Biol; 2018 Dec; 53():223-231. PubMed ID: 30130664
[TBL] [Abstract][Full Text] [Related]
19. miR-186 and 326 predict the prognosis of pancreatic ductal adenocarcinoma and affect the proliferation and migration of cancer cells.
Zhang ZL; Bai ZH; Wang XB; Bai L; Miao F; Pei HH
PLoS One; 2015; 10(3):e0118814. PubMed ID: 25742499
[TBL] [Abstract][Full Text] [Related]
20. Metabolism remodeling in pancreatic ductal adenocarcinoma.
Li JT; Wang YP; Yin M; Lei QY
Cell Stress; 2019 Nov; 3(12):361-368. PubMed ID: 31832601
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
